Purchase Order 75N94019P00765

Award Date 8/20/19
Potential Completion Date 6/30/20
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Horizon Discovery LIMITED, a UK-based for-profit biotechnology company. The $30,805.00 contract is for genome editing testing services, with an ultimate completion date of December 31, 2015. The contract does not have a set-aside designation....
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,235.00 firm-fixed-price purchase order contract to Horizon Discovery Limited, a for-profit biotechnology company based in the United Kingdom. The contract is for the provision of custom human cell lines to support biomedical research, with a completion date of December 13, 2019. No set-aside was used for this award. Horizon Discovery...
The Department of Health and Human Services' National Institutes of Health's National Center for Advancing Translational Sciences awarded a $13,474 purchase order to Horizon Discovery Biosciences Limited of Great Britain. Under the firm fixed price contract, Horizon Discovery will provide ON-TARGETPLUS MOUSE AAK1 small interfering RNA SMARTPOOL consisting of 50 nanomoles of the described product. Place of performance will be Great Britain, with work occurring between September 5 and November...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NIH NCATS) awarded a $122,612.40 firm fixed-price purchase order to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, for 14 Mouse ON-TARGET plus small interfering RNA (siRNA) libraries. This non-competitive, brand-name acquisition was conducted under simplified acquisition procedures without any small business set-aside. The purchase...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Horizon Discovery Limited, a UK-based biotechnology company, for whole-genome CRISPR knockout gene interaction screening services. The contract, valued at $92,500, was awarded in support of NICHD research to translate genomic and genetic research into a greater understanding of human genetic disease and the...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER DETECTION KIT, which is used exclusively with the PATHHUNTER CELL LINES from Eurofins Discoverx. The contract has a ceiling value of $24,831.22 and a period of performance ending...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,830.00 firm-fixed-price purchase order to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, for the provision of PATHHUNTER CHO-K1 DRD3 ARRESTIN CELL LINE and U2OS DRD3 ARRESTIN CELL LINE. This award is not associated with any set-aside program. Eurofins Discoverx Corporation is a leading provider of innovative cell-based assays...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Discovery Life Sciences, LLC, a small disadvantaged business, on August 2, 2022. The contract has a ceiling value of $48,945.00 and a completion date of November 1, 2022. The contract is for the procurement of primary human hepatocytes and media, as requested in the FDA's Sources Sought Notice FDA-SSN-1252684. Discovery Life Sciences has over a decade of experience supporting federal agencies'...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Disposition Services to Horizon Environmental Services, Inc., doing business as Horizon Environmental Enterprises. The contract has a ceiling value of $4,091.00 and is for the provision of paints and coatings with non-reactive components. The delivery order was issued under a larger single-award indefinite delivery contract (IDC) between Horizon and the DLA Disposition Services, which has a potential value exceeding $31...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...

HORIZON DISCOVERY LTD:1211345 [19-008693]

Posted 8/20/19, 12:00 AM